Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Sequential and direct ionic excitation in the strong-field ionization of 1-butene molecules.

Schell F, Boguslavskiy AE, Schulz CP, Patchkovskii S, Vrakking MJJ, Stolow A, Mikosch J.

Phys Chem Chem Phys. 2018 May 30;20(21):14708-14717. doi: 10.1039/c7cp08195b.

PMID:
29774327
2.

Molecular orbital imprint in laser-driven electron recollision.

Schell F, Bredtmann T, Schulz CP, Patchkovskii S, Vrakking MJJ, Mikosch J.

Sci Adv. 2018 May 4;4(5):eaap8148. doi: 10.1126/sciadv.aap8148. eCollection 2018 May.

3.

CEP-stable few-cycle pulses with more than 190  μJ of energy at 100  kHz from a noncollinear optical parametric amplifier.

Furch FJ, Witting T, Giree A, Luan C, Schell F, Arisholm G, Schulz CP, Vrakking MJJ.

Opt Lett. 2017 Jul 1;42(13):2495-2498. doi: 10.1364/OL.42.002495.

PMID:
28957267
4.
5.

Physiological and psychological effects of Hatha-Yoga exercise in healthy women.

Schell FJ, Allolio B, Schonecke OW.

Int J Psychosom. 1994;41(1-4):46-52.

PMID:
7843867
6.

Analysis of chemicals from earthworms and fish that elicit prey attack by ingestively naive garter snakes (Thamnophis).

Schell FM, Burghardt GM, Johnston A, Coholich C.

J Chem Ecol. 1990 Jan;16(1):67-77. doi: 10.1007/BF01021268.

PMID:
24264896
7.

Comparison of earthworm- and fish-derived chemicals eliciting prey attack by garter snakes (Thamnophis).

Burghardt GM, Goss SE, Schell FM.

J Chem Ecol. 1988 Mar;14(3):855-81. doi: 10.1007/BF01018779.

PMID:
24276137
8.

Cell surface polysaccharides from Bradyrhizobium japonicum and a nonnodulating mutant.

Puvanesarajah V, Schell FM, Gerhold D, Stacey G.

J Bacteriol. 1987 Jan;169(1):137-41.

9.

Role for 2-linked-beta-D-glucan in the virulence of Agrobacterium tumefaciens.

Puvanesarajah V, Schell FM, Stacey G, Douglas CJ, Nester EW.

J Bacteriol. 1985 Oct;164(1):102-6.

10.

Responses by king snakes (Lampropeltis getulus) to chemicals from colubrid and crotaline snakes.

Weldon PJ, Schell FM.

J Chem Ecol. 1984 Oct;10(10):1509-20. doi: 10.1007/BF00990320.

PMID:
24318350
11.

Phase I-II study of high-dose mitomycin with autologous bone marrow transplantation in refractory metastatic breast cancer.

Tannir N, Spitzer G, Dicke K, Schell F, DiStefano A, Blumenschein G.

Cancer Treat Rep. 1984 May;68(5):805-6. No abstract available.

PMID:
6426793
12.

Adjuvant chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide, with or without Bacillus Calmette-Guerin and with or without irradiation in operable breast cancer. A prospective randomized trial.

Buzdar AU, Blumenschein GR, Smith TL, Powell KC, Hortobagyi GN, Yap HY, Schell FC, Barnes BC, Ames FC, Martin RG, et al.

Cancer. 1984 Feb 1;53(3):384-9.

PMID:
6362814
13.

Phase II study of high-dose amsacrine (AMSA) and autologous bone marrow transplantation in patients with refractory metastatic breast cancer.

Tannir N, Spitzer G, Schell F, Legha S, Zander A, Blumenschein G.

Cancer Treat Rep. 1983 Jun;67(6):599-600. No abstract available.

PMID:
6344995
14.

Bisantrene, an active new drug in the treatment of metastatic breast cancer.

Yap HY, Yap BS, Blumenschein GR, Barnes BC, Schell FC, Bodey GP.

Cancer Res. 1983 Mar;43(3):1402-4.

15.

Multimodal treatment of locoregionally advanced breast cancer.

Hortobagyi GN, Blumenschein GR, Spanos W, Montague ED, Buzdar AU, Yap HY, Schell F.

Cancer. 1983 Mar 1;51(5):763-8.

PMID:
6687377
16.

Phase II clinical evaluation of AZQ in metastatic breast cancer.

Yap HY, Bedikian AY, Schell FC, Blumenschein GR, Bodey GP.

Am J Clin Oncol. 1983 Feb;6(1):31-3.

PMID:
6837505
17.

Combination chemotherapy with continuous infusion vinblastine and peptichemio for patients with advanced metastatic breast cancer.

Yap HY, Blumenschein GR, Hortobagyi GN, Buzdar AU, Schell FC, Bodey GP.

Am J Clin Oncol. 1982 Oct;5(5):511-4.

PMID:
7180829
18.

Potential cardiotoxicity with mitoxantrone.

Schell FC, Yap HY, Blumenschein G, Valdivieso M, Bodey G.

Cancer Treat Rep. 1982 Aug;66(8):1641-3.

PMID:
7105054
19.

Peptichemio versus melphalan (L-PAM) in advanced breast cancer.

Buzdar AU, Legha SS, Blumenschein GR, Hortobagyi GN, Yap HY, Schell FC, Barnes BC, Fraschini G, Bodey GP.

Cancer. 1982 May 1;49(9):1767-70.

PMID:
7042074
20.

High-dose AMSA and bone marrow rescue in patients with solid tumors.

Zander AR, Spitzer G, Legha S, Dicke DA, Verma DS, Johnston DA, Vellekoop L, Beran M, Schell F, Minnhaar G, Blumenschein GR, Bodey GP.

Cancer Treat Rep. 1982 Feb;66(2):385-6.

PMID:
7034935
21.

Phase II study of VP16-213 (etoposide) in refractory metastatic breast carcinoma.

Schell FC, Yap HY, Hortobagyi GN, Issell B, Esparza L.

Cancer Chemother Pharmacol. 1982;7(2-3):223-5. No abstract available.

PMID:
7083463
22.

Dihydroxyanthracenedione: a promising new drug in the treatment of metastatic breast cancer.

Yap HY, Blumenschein GR, Schell FC, Buzdar AU, Valdivieso M, Bodey GP.

Ann Intern Med. 1981 Dec;95(6):694-7.

PMID:
7305147
23.

Management of breast cancer patients failing adjuvant chemotherapy with adriamycin-containing regimens.

Buzdar AU, Legha SS, Hortobagyi GN, Yap HY, Wiseman CL, Distefano A, Schell FC, Barnes BC, Campos LT, Blumenschein GR.

Cancer. 1981 Jun 15;47(12):2798-802.

PMID:
7260870
24.

Phase II evaluation of methyl-GAG in patients with refractory metastatic breast cancer.

Yap HY, Blumenschein GR, Schell F, Bodey GP.

Cancer Treat Rep. 1981 May-Jun;65(5-6):465-7.

PMID:
7237467
25.

Autologous bone marrow transplantation in neoplasia.

Dicke KA, Vellekoop L, Spitzer G, Zander AR, Schell F, Verma DS.

Transplant Proc. 1981 Mar;13(1 Pt 1):267-9. No abstract available.

PMID:
6267751
26.

Combination chemoimmunotherapy with FAC-BCG for metastatic breast cancer: the impact of CMF maintenance chemotherapy.

Hortobagyi GN, Blumenschein GR, Buzdar AU, Yap HY, Schell FC, Barnes BC, Burgess MA.

J Surg Oncol. 1981;18(2):163-72.

PMID:
7300363
27.

[Pharmacy in the event of catastrophe].

Schell F.

MMW Munch Med Wochenschr. 1980 Oct 17;122(42):1463-6. German.

PMID:
6780835
28.

Clinical note. Esophageal rupture in a premature infant.

Khanna NN, Wijesekera S, Cushmore FN, Schell FR.

J Pediatr. 1978 Apr;92(4):641-2. No abstract available.

PMID:
344849
29.

Isolation and characterization of a hypoglycemic agent from Xanthium strumarium.

Kupiecki FP, Ogzewalla CD, Schell FM.

J Pharm Sci. 1974 Jul;63(7):1166-7. No abstract available.

PMID:
4852580
30.

Carbon-13 nuclear magnetic resonance spectroscopy of naturally occurring substances. XIX. Aspidosperma alkaloids.

Wenkert E, Cochran DW, Hagaman EW, Schell FM, Neuss N, Katner AS, Potier P, Kan C, Plat M, Koch M, Mehri H, Poisson J, Kunesch N, Rolland Y.

J Am Chem Soc. 1973 Jul 25;95(15):4990-5. No abstract available.

PMID:
4741281
31.

The structure of vincarodine.

Neuss N, Boaz HE, Occolowitz JL, Wenkert E, Schell FM, Potier P, Kan C, Plat MM, Plat M.

Helv Chim Acta. 1973 Jul;56(7):2660-6. No abstract available.

PMID:
4761281
32.

CMR spectral analysis of tetrahydrocannabinol and its isomers.

Wenkert E, Cochran DW, Schell FM, Archen RA, Matsumoto K.

Experientia. 1972 Mar 15;28(3):250-1. No abstract available.

PMID:
5026417
33.

Apomorphine HCL stabilization.

Engelhardt RJ, Schell FM, Lichtin JL.

J Am Pharm Assoc. 1968 Apr;8(4):198-9. No abstract available.

PMID:
5660501
34.

Cultivation of equine abortion virus in fetal horse tissue in vitro.

RANDALL CC, RYDEN FW, DOLL ER, SCHELL FS.

Am J Pathol. 1953 Jan-Feb;29(1):139-53. No abstract available.

35.

Detection by tissue culture of an organism resembling Histoplasma capsulatum in an apparently healthy horse.

RANDALL CC, ORR MF, SCHELL FG.

Proc Soc Exp Biol Med. 1951 Nov;78(2):447-50. No abstract available.

PMID:
14911911
36.

Blastomycosis in a dog; case report.

ROBINSON VB, SCHELL FG.

North Am Vet. 1951 Aug;32(8):555-8. No abstract available.

PMID:
14853272
37.

Report of a case of hydrometrocolpos; a congenital dilatation of the female genital tract.

SCHELL FR.

Radiology. 1948 Aug;51(2):252-6. No abstract available.

PMID:
18878323
38.

Equine insemination, pro and con.

SCHELL FG.

North Am Vet. 1948 Jul;29(7):413-7. No abstract available.

PMID:
18867319

Supplemental Content

Loading ...
Support Center